BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32430933)

  • 21. Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.
    Nelson ND; Marcogliese A; Bergstrom K; Scheurer M; Mahoney D; Bertuch AA
    Pediatr Blood Cancer; 2016 Aug; 63(8):1484-7. PubMed ID: 27100794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombocythemia 1 With
    Jung N; Kim DH; Ha JS; Shim YJ
    Ann Lab Med; 2020 Jul; 40(4):341-344. PubMed ID: 32067437
    [No Abstract]   [Full Text] [Related]  

  • 23. MPL Baltimore mutation and thrombocytosis: case report and literature review.
    Shkalim-Zemer V; Dgany O; Krasnov T; Yacobovich J; Tamary H
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e112-4. PubMed ID: 23511495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells through alternative splicing of c-Mpl.
    Xiao N; Laha S; Das SP; Morlock K; Jesneck JL; Raffel GD
    Blood; 2015 Feb; 125(6):941-8. PubMed ID: 25468569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline
    Aral B; Courtois M; Ragot S; Bourgeois V; Bottolier-Lemallaz E; Briandet C; Girodon F
    Haematologica; 2018 Aug; 103(8):e372-e373. PubMed ID: 29567786
    [No Abstract]   [Full Text] [Related]  

  • 26. Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation.
    Verger E; Teillet F; Conejero C; Letort G; Chomienne C; Giraudier S; Cassinat B
    Br J Haematol; 2016 Oct; 175(1):167-9. PubMed ID: 26568271
    [No Abstract]   [Full Text] [Related]  

  • 27. Hereditary thrombocytosis not as innocent as thought? Development into acute leukemia and myelofibrosis.
    Posthuma HL; Skoda RC; Jacob FA; van der Maas AP; Valk PJ; Posthuma EF
    Blood; 2010 Oct; 116(17):3375-6. PubMed ID: 21030572
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression.
    Nakayama H; Ihara K; Hikino S; Yamamoto J; Nagatomo T; Takemoto M; Hara T
    J Mol Med (Berl); 2005 Apr; 83(4):316-20. PubMed ID: 15647951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.
    McMullin MF
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):391-396. PubMed ID: 31808840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of hereditary thrombocythemia and distal limb defects with a thrombopoietin gene mutation.
    Graziano C; Carone S; Panza E; Marino F; Magini P; Romeo G; Pession A; Seri M
    Blood; 2009 Aug; 114(8):1655-7. PubMed ID: 19553636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombocytosis and Effects of IL-6 Knock-Out in a Colitis-Associated Cancer Model.
    Josa V; Ferenczi S; Szalai R; Fuder E; Kuti D; Horvath K; Hegedus N; Kovacs T; Bagamery G; Juhasz B; Winkler Z; Veres DS; Zrubka Z; Mathe D; Baranyai Z
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary and secondary thrombocytosis in childhood.
    Dame C; Sutor AH
    Br J Haematol; 2005 Apr; 129(2):165-77. PubMed ID: 15813844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26.
    Schnittger S; de Sauvage FJ; Le Paslier D; Fonatsch C
    Leukemia; 1996 Dec; 10(12):1891-6. PubMed ID: 8946927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis.
    Percy MJ; Rumi E
    Am J Hematol; 2009 Jan; 84(1):46-54. PubMed ID: 19006225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline JAK2 mutation in a family with hereditary thrombocytosis.
    Mead AJ; Rugless MJ; Jacobsen SE; Schuh A
    N Engl J Med; 2012 Mar; 366(10):967-9. PubMed ID: 22397670
    [No Abstract]   [Full Text] [Related]  

  • 36. Splicing of constitutive upstream introns is essential for the recognition of intra-exonic suboptimal splice sites in the thrombopoietin gene.
    Romano M; Marcucci R; Baralle FE
    Nucleic Acids Res; 2001 Feb; 29(4):886-94. PubMed ID: 11160920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.
    Yoshimi A; Abdel-Wahab O
    Int J Hematol; 2017 Jun; 105(6):720-731. PubMed ID: 28466384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytosis in an infant with high thrombopoietin concentrations.
    Hankins J; Naidu P; Rieman M; Wang W; Kaushansky K; Rodriguez-Galindo C
    J Pediatr Hematol Oncol; 2004 Feb; 26(2):142-5. PubMed ID: 14767209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis with Cooccurrent SF3B1 and MPL Gene Mutations: A Case Report and Brief Review of the Literature.
    Park CH; Yun JW; Kim HY; Lee KO; Kim SH; Kim HJ
    Lab Med; 2020 May; 51(3):315-319. PubMed ID: 31858134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.